Cancer
ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
Individualized Medicine
November 29, 2023
Individualized Medicine
November 21, 2023
Cardiovascular
November 13, 2023
Sign up to receive email notifications
Explore more topics
Sign up
Mayo Clinic Connect
An online patient support community